JP Morgan Chase’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Sell
213,241
-10,573
-5% -$1.2M ﹤0.01% 1999
2025
Q4
$23.8M Sell
223,814
-152,980
-41% -$15.4M ﹤0.01% 1918
2025
Q3
$35.3M Buy
376,794
+6,713
+2% +$624K ﹤0.01% 1649
2025
Q2
$32.1M Sell
370,081
-115,288
-24% -$9.64M ﹤0.01% 1618
2025
Q1
$37.4M Sell
485,369
-5,585
-1% -$512K ﹤0.01% 1481
2024
Q4
$47.5M Buy
490,954
+70,919
+17% +$7.13M ﹤0.01% 1360
2024
Q3
$39.8M Sell
420,035
-7,357
-2% -$642K ﹤0.01% 1472
2024
Q2
$35.6M Buy
427,392
+248,478
+139% +$20.7M ﹤0.01% 1440
2024
Q1
$15.4M Buy
178,914
+63,235
+55% +$5.15M ﹤0.01% 2108
2023
Q4
$9.56M Buy
115,679
+9,462
+9% +$694K ﹤0.01% 2517
2023
Q3
$7.64M Sell
106,217
-14,475
-12% -$1.1M ﹤0.01% 2501
2023
Q2
$9.14M Buy
120,692
+14,486
+14% +$974K ﹤0.01% 2361
2023
Q1
$6.7M Buy
106,206
+14,480
+16% +$850K ﹤0.01% 2597
2022
Q4
$4.98M Sell
91,726
-95,768
-51% -$5.69M ﹤0.01% 2815
2022
Q3
$10.7M Buy
187,494
+3,401
+2% +$189K ﹤0.01% 2103
2022
Q2
$8.55M Buy
184,093
+14,376
+8% +$753K ﹤0.01% 2299
2022
Q1
$9.72M Sell
169,717
-33,748
-17% -$1.74M ﹤0.01% 2403
2021
Q4
$10.7M Sell
203,465
-169,538
-45% -$9.07M ﹤0.01% 2391
2021
Q3
$18.7M Buy
373,003
+69,466
+23% +$3.6M ﹤0.01% 1826
2021
Q2
$17.8M Sell
303,537
-91,406
-23% -$5.65M ﹤0.01% 1941
2021
Q1
$25.7M Buy
394,943
+36,116
+10% +$2.22M ﹤0.01% 1547
2020
Q4
$19.7M Sell
358,827
-8,775
-2% -$448K ﹤0.01% 1622
2020
Q3
$16.3M Sell
367,602
-44,957
-11% -$1.98M ﹤0.01% 1640
2020
Q2
$17.4M Sell
412,559
-25,327
-6% -$974K ﹤0.01% 1463
2020
Q1
$17.4M Buy
437,886
+345,477
+374% +$14.6M ﹤0.01% 1350
2019
Q4
$4.12M Sell
92,409
-1,167
-1% -$44.9K ﹤0.01% 2839
2019
Q3
$3.2M Sell
93,576
-74,876
-44% -$2.59M ﹤0.01% 3078
2019
Q2
$6.23M Buy
168,452
+8,058
+5% +$276K ﹤0.01% 2461
2019
Q1
$4.9M Buy
160,394
+68,670
+75% +$2.1M ﹤0.01% 2605
2018
Q4
$2.54M Buy
+91,724
New +$2.52M ﹤0.01% 3114

Other funds holding ACA

JP Morgan Chase's ACA Position: Q1 2026 in Review

JP Morgan Chase reduced its Arcosa (ACA) stake by 4.7% in Q1 2026, selling an estimated $1.2M and leaving 213,241 shares worth $21.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

JP Morgan Chase first reported a position in ACA in Q4 2018 and has held it in 30 quarters since. The position peaked at $47.5M in Q4 2024. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

  • JP Morgan Chase held 213,241 shares of Arcosa worth $21.8M as of Q1 2026.
  • JP Morgan Chase sold 10,573 Arcosa shares in Q1 2026, an estimated $1.2M.
  • Arcosa made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1999 holding.
  • JP Morgan Chase first reported a position in Arcosa in Q4 2018 and has held it in 30 quarters since.
  • JP Morgan Chase's Arcosa position peaked at $47.5M in Q4 2024.
  • 372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.